Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein
- 5 August 2022
- journal article
- research article
- Published by Springer Nature in Pharmacological Reports
- Vol. 74 (6) , 1315-1325
Abstract
Background COVID-19, the disease caused by SARS-CoV-2 virus infection, has been a major public health problem worldwide in the last 2 years. SARS-CoV-2-dependent activation of innate immune receptors contributes to the strong local and systemic inflammatory reaction associated with rapid disease evolution. The receptor-binding domain (RBD) of Spike (S) viral protein (S-RBD) is essential for virus infection and its interacting molecules in target cells are still under identification. On the other hand, the search for accessible natural molecules with potential therapeutic use has been intense and remains an active field of investigation. Methods C57BL6/J (control) and Toll-like receptor (TLR) 4-deficient (Lps del) mice were nebulized with recombinant S-RBD. Tumor Necrosis Factor-alpha (TNF-α) and Interleukin (IL)-6 production in bronchoalveolar lavages (BALs) was determined by enzyme-linked immunosorbent assay (ELISA). Lung-infiltrating cells recovered in BALs were quantified by hematoxylin–eosin (H&E) stain. In selected groups of animals, the natural compound Jacareubin or dexamethasone were intraperitoneally (ip) administered 2 hours before nebulization. Results A rapid lung production of TNF-α and IL-6 and cell infiltration was induced by S-RBD nebulization in control but not in Lps del mice. Pre-treatment with Jacareubin or dexamethasone prevented S-RBD-induced TNF-α and IL-6 secretion in BALs from control animals. Conclusions S-RBD domain promotes lung TNF-α and IL-6 production in a TLR4-dependent fashion in C57BL6/J mice. Xanthone Jacareubin possesses potential anti-COVID-19 properties that, together with the previously tested anti-inflammatory activity, safety, and tolerance, make it a valuable drug to be further investigated for the treatment of cytokine production caused by SARS-CoV-2 infection.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (CF-2019-51488, CB2017-2018 A1-S-10743, 311835)
- Secretaría de Educación Pública-Cinvestav (2018:1)
- Secretaría de Relaciones Exteriores (AMEXCID_2020-3)
- Gobierno del Estado de Hidalgo (Sincrotrón 20201120, 20201039)
This publication has 32 references indexed in Scilit:
- Structure analysis of the receptor binding of 2019-nCoVBiochemical and Biophysical Research Communications, 2020
- Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS CoronavirusJournal of Virology, 2020
- Xiaozhang Tie Improves Intestinal Motility in Rats With Cirrhotic Ascites by Regulating the Stem Cell Factor/c-kit Pathway in Interstitial Cells of CajalFrontiers in Pharmacology, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Jacareubin inhibits FcεRI-induced extracellular calcium entry and production of reactive oxygen species required for anaphylactic degranulation of mast cellsBiochemical Pharmacology, 2018
- Cytogenetic effects of Jacareubin from Calophyllum brasiliense on human peripheral blood mononucleated cells in vitro and on mouse polychromatic erythrocytes in vivoToxicology and Applied Pharmacology, 2017
- Murine Bronchoalveolar LavageBio-Protocol, 2017
- Solution Structure of the Kaposi's Sarcoma-associated Herpesvirus K3 N-terminal Domain Reveals a Novel E2-binding C4HC3-type RING DomainJournal of Biological Chemistry, 2004
- Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxinAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Limits of a deletion spanning Tlr4 in C57BL/10ScCr miceInnate Immunity, 2000